https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/gliosarcoma-clinical-trial
Neuro-oncologist Mark Gilbert, M.D., shares information about a clinical trial at NIH investigating the effectiveness of a cancer drug to treat people with...
clinical trialtreatgliosarcomaprimarycns
https://www.pharmaceutical-technology.com/data-insights/pembrolizumab-merck-gliosarcoma-likelihood-of-approval/?utm_source=lgp5-loa&utm_medium=24-216108&utm_campaign=recommended-articles-pi
Pembrolizumab is under clinical development by Merck and currently in Phase II for Gliosarcoma.
pembrolizumabmerckgliosarcomalikelihoodapproval